Boldi Nagorniuk, MBA, leads Client Success at RIS Rx. He brings extensive pharmaceutical, distribution, and market access experience, including leadership roles in trade relations and distribution at Arcutis, Alexion and Portola, plus earlier market access and commercial roles at Boehringer Ingelheim and AstraZeneca. He holds a BA from the University of California, Los Angeles, and an MBA from the University of Central Oklahoma.
Learn why the world's top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.
RIS Rx is pioneering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patients at the right time.